NIH Unperturbed by New Way of Peering into Personal Genomic Data
By Jocelyn Kaiser,
Science Insider
| 04. 10. 2012
In a provocative paper published this week, researchers say they have figured out a way to link a person's DNA to their anonymous genetic data in a certain kind of public research database. But the National Institutes of Health (NIH), which hosts one of the largest such databases, says it's not taking any new steps to prevent someone from using the method to breach privacy. That contrasts with NIH's response 4 years ago, when a similar study prompted the agency to pull genetic data from its public Web sites.
The issue then involved studies that compare DNA variants called single nucleotide polymorphisms (SNPs) in people with and without an illness to find disease risk markers. NIH had begun posting online pooled SNP results from hundreds of people, thinking privacy would not be breached. But then scientists reported in PloS Genetics that if they had a sample of an individual's DNA, they could link it to that person's SNP results within a public DNA pool. NIH (and the Wellcome Trust)
removed data from public sites; NIH now allows only approved...
Related Articles
By Keith Casebonne and Jodi Beckstine [with CGS' Katie Hasson], Disability Deep Dive | 07.24.2025
In this episode of Disability Deep Dive, hosts Keith and Jodi explore the complex interplay between disability science, technology, and ethics with guest Katie Hasson, Associate Director at the Center for Genetics and Society. The conversation delves into...
By Angus Liu, Fierce Pharma | 07.22.2025
A brief skirmish between Sarepta Therapeutics and the FDA has ended before escalating into a full-on regulatory clash, as the company has bowed to the agency’s demand.
In a surprising reversal, Sarepta on Monday said it will pause all shipments...
By Lucy Tu, The Atlantic | 07.11.2025
Donald Trump—who is, by his own accounting, “the fertilization president” and “the father of IVF”—wants to help Americans reproduce. During his 2024 campaign, he promised that the government or insurance companies would cover the cost of in vitro fertilization. In...
By Jared Whitlock, Endpoints News | 07.15.2025
Patient groups face a harder and unpredictable path going state-by-state to boost screening for rare but treatable conditions after the Trump administration disbanded a federal advisory committee on newborn screening.
In April, the Advisory Committee on Heritable Disorders in Newborns...